Newsroom | Emcure Pharmaceuticals

Newsroom

Emcure in News

For media queries, write to: naveen.soni@emcure.co.in (Corporate Communications)

Newsroom

Press release

Emcure Pharma invested 400 cr at Sanand plant

India likely to get first mRNA vax by year-end

Gennova to use mRNA tech to develop Vax for Zika,TB

Emcure Pharma strengthens its board, adds 4 Independent Directors

Gennova likely to become second vaccine maker to receive advance from Centre

EXPLAINED: Why India-Made Gennova Vax Could Give Protection At A Fraction Of Cost Of Other mRNA Shots

Gennova Likely to Submit Data of Phase-I Trial of India’s 1st mRNA Vaccine By This Month

Naveen Soni joins Emcure Pharmaceuticals as Director – Corporate Communications and Public Relations

Emcure says it will continue growth momentum in FY22 by deepening product portfolio, digital focus

Trials of India’s first mRNA Covid vaccine by Gennova on track

Gennova seeks to start trials of indigenous mRNA vaccine- Mint

Gennova Biopharma to start mRNA vaccine trials this month- Business Today

Emcure says Gennova is working on backward integration of its mRNA COVID-19 vaccine- Moneycontrol

Clinical trials on India’s first mRNA Covid-19 vaccine to begin soon

Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report- NDTV

Emcure Pharmaceuticals Ltd launches Uncondition Yourself – an initiative dedicated to women’s health and wellness- ANI News

Quick Explore